Anzeige
Mehr »
Montag, 08.09.2025 - Börsentäglich über 12.000 News
Tokenisierung entfesselt: Republic führt die Ethereum-Revolution
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J68D | ISIN: CNE100001M79 | Ticker-Symbol: 08HH
Frankfurt
08.09.25 | 19:34
2,898 Euro
+14,36 % +0,364
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD Chart 1 Jahr
5-Tage-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
2,8142,95421:00
2,8082,95421:00

Aktuelle News zur SHANGHAI FOSUN PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12:26FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL OF DRUG CLINICAL TRIAL OF A SUBSIDIARY1
06:17HSI Closes Midday at 25,508, Up 90 pts; HSTI Closes Midday at 5,702, Up 15 pts; BABA Up over 3%; WUXI BIO, CHOW TAI FOOK, FOSUN PHARMA, HORIZONROBOT-W, CHINA LESSO Hit New Highs24
29.08.Accro Bioscience Grants Fosun Pharma Exclusive Rights for TYK2/JAK1 Inhibitor in Greater China20
28.08.CLSA: FOSUN PHARMA ESOP Enhances Growth Visibility; TP Elevated to $29.65
27.08.China's Fosun Pharma Grants UK Peer Sitala Overseas Rights to Its Innovative Drug5
SHANGHAI FOSUN PHARMACEUTICAL Aktie jetzt für 0€ handeln
26.08.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE OF A SUBSIDIARY'S DRUG REGISTRATION APPLICATION-
26.08.FOSUN PHARMA (02196): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 20253
26.08.Fosun Pharma Announces 2025 Interim Results431Enhancing Innovation Efficiency and Steadily Expanding Globally SHANGHAI, Aug. 26, 2025 /PRNewswire/ -- On August 26, 2025, Shanghai Fosun Pharmaceutical (Group)...
► Artikel lesen
26.08.FOSUN PHARMA (02196): DISCLOSEABLE AND CONTINUING CONNECTED TRANSACTION RENEWAL OF FINANCIAL SERVICES AGREEMENT3
22.08.FOSUN PHARMA (02196): PROPOSED ADOPTION OF THE 2025 A SHARE OPTION SCHEME5
12.08.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE OF A SUBSIDIARY'S DRUG REGISTRATION APPLICATION16
12.08.Fosun Pharma Rises After Unit Sells Rights to Novel Lung Disease Drug Outside China for USD645 Million7
12.08.FOSUN PHARMA Surges 7%+ at Open; Potential Value of Overseas Licensing for Small-Molecule Oral DPP-1 Inhibitor Totals USD645M6
12.08.HSI Loses 82Pts at Open; BABA-W Soft; FOSUN PHARMA Up21
08.08.FOSUN PHARMA (02196): VOLUNTARY ANNOUNCEMENT - COMPLETION OF THE ISSUANCE OF THE SECOND TRANCHE SCIENTIFIC AND TECHNOLOGICAL INNOVATION BONDS FOR 20255
08.08.FOSUN PHARMA (02196): DATE OF BOARD MEETING8
30.07.AriBio Signs Exclusive Licensing Deal with China's Fosun Pharma for Alzheimer's Drug6
29.07.Fosun Pharma Secures Rights to Novel Alzheimer's Drug in China16
24.07.Dividendenbekanntmachungen (24.07.2025)7.864 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  APTARGROUP INC  US0383361039  0,45 USD  0,3823 EUR  BLOOMSBURY PUBLISHING PLC  GB0033147751  0,1154 GBP  0,1331 EUR  CALNEX SOLUTIONS PLC  GB00BMBK7016  0...
► Artikel lesen
15.07.FOSUN PHARMA (02196): CONNECTED TRANSACTION - CAPITAL REDUCTION OF SUZHOU ANGEL FUND18
Weiter >>
88 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1